Live from the NIH registry
Studies recruiting near Peoria right now
Top 25 of 219 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Illinois Cancer Care — Peoria, Illinois (4.3 mi)
· Sponsor: SCRI Development Innovations, LLC
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
AMI Cardiogenic Shock
N/A
Observational 350 participants sought
OSF Saint Francis — Peoria, Illinois (4.3 mi)
· Sponsor: Abiomed Inc.
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Peoria, Illinois (4.3 mi)
· Sponsor: Daiichi Sankyo
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
OSF HealthCare Cancer Institute — Peoria, Illinois (4.3 mi)
· Sponsor: Proton Collaborative Group
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Illinois CancerCare — Peoria, Illinois (4.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
OSF Saint Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: Penumbra Inc.
A Study of ZL-1310 in Participants With Selected Solid Tumors
Solid Tumors
Phase 1, Phase 2
Interventional 166 participants sought
OSF St. Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: Zai Lab (Shanghai) Co., Ltd.
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
Normal and Diseased Tissue and Body Fluids Samples
N/A
Observational 100,000 participants sought
Children's Hospital of Illinois at OSF-Saint Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: St. Jude Children's Research Hospital
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: SWOG Cancer Research Network
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Phase 3
Interventional 736 participants sought
Illinois CancerCare PC — Peoria, Illinois (4.3 mi)
· Sponsor: BioNTech SE
Stress Hydrocortisone In Pediatric Septic Shock
Septic Shock
Phase 3
Interventional 500 participants sought
The University of Illinois at Chicago/OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: Jerry Zimmerman
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Local Institution - Unk061 — Peoria, Illinois (4.3 mi)
· Sponsor: Mirati Therapeutics Inc.
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: NRG Oncology
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
Acute Respiratory Distress Syndrome (ARDS), ARDS
Phase 2
Interventional 200 participants sought
OSF Saint Francis Medical Center- — Peoria, Illinois (4.3 mi)
· Sponsor: PPD Development, LP
Pounce™ Thrombectomy System Retrospective Registry
Peripheral Arterial Disease, Acute Limb Ischemia
N/A
Observational 500 participants sought
OSF St. Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: SurModics, Inc.
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
Illinois CancerCare — Peoria, Illinois (4.3 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study of BG-C477 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 310 participants sought
Osf Saint Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: BeOne Medicines
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Pulmonary Hypertension Associated With HFpEF
Phase 3
Interventional 540 participants sought
Tenax Investigational Site — Peoria, Illinois (4.3 mi)
· Sponsor: Tenax Therapeutics, Inc.
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 335 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age
Hyperkalemia
Phase 2
Interventional 32 participants sought
University of Illinois College of Medicine — Peoria, Illinois (4.3 mi)
· Sponsor: Vifor Pharma, Inc.
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: Wake Forest University Health Sciences
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
Illinois Eye Center - Peoria Location /ID# 277127 — Peoria, Illinois (4.3 mi)
· Sponsor: AbbVie